Investors
David J. Brailer, MD, PhD
Ned Brown
Sarah Chang
Thomas P. Chung
Rolf Classon
Bradley M. Fluegel
Adam Grossman
Aadam Hussain
Braden Kelly
Christopher McFadden
Julie Murchinson
Peter Neupert
Carter Paine
Reid S. Perper
Jay B. Rose, MD
Joshua Saipe
Barry Smith
Kevin Tseng
Jacqueline Valdez
Kay Yun
Carl Zimmerman
Braden Kelly
Senior Advisor
bkelly@healthevolutionpartners.com
Braden is a member of the Health Evolution Partners Growth Fund’s Investment Committee.
Boards of Directors:
Braden has served on public and private boards of heath care technology, health care services, technology and IT services companies as well as being a strategic advisor to health care, technology and investment firms.
Select Experience:
General Atlantic: While a partner and managing director of this global $13 billion private equity investment firm, Braden originated and ran the firm’s global health care practice; started the firm’s West Coast office; and was on the firm’s investment committee. During his 12 year tenure, the healthcare group successfully invested over $1 billion in investments in the U.S., Europe and India including Envoy Corporation, Eclipsys Corporation, Trinet Inc., Schaller Anderson, GWI AG, iSoft Group plc. and Jubilant Organosys.
Morgan Stanley & Co.: Braden was an investment banker in the mergers, acquisitions and restructuring department.
Education:
Bachelor’s degree, summa cum laude, finance and business economics, University of Notre Dame
